Cargando…

Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability

Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (βCD) cycle and argi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukomanovic, Marija, Gazvoda, Lea, Kurtjak, Mario, Hrescak, Jitka, Jaklic, Blaž, Moya-Andérico, Laura, Cendra, Maria del Mar, Torrents, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653501/
https://www.ncbi.nlm.nih.gov/pubmed/36371541
http://dx.doi.org/10.1038/s42003-022-04197-9
_version_ 1784828699999207424
author Vukomanovic, Marija
Gazvoda, Lea
Kurtjak, Mario
Hrescak, Jitka
Jaklic, Blaž
Moya-Andérico, Laura
Cendra, Maria del Mar
Torrents, Eduard
author_facet Vukomanovic, Marija
Gazvoda, Lea
Kurtjak, Mario
Hrescak, Jitka
Jaklic, Blaž
Moya-Andérico, Laura
Cendra, Maria del Mar
Torrents, Eduard
author_sort Vukomanovic, Marija
collection PubMed
description Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (βCD) cycle and arginine (arg) as a linker, provides more stable ternary antibiotic complex (βCD-arg-cpx). In contrast to classical less stable inclusion complexes, which only modify antibiotic solubility, here-presented ternary complex is more stable and controls drug release. The components of the complex intensify interactions with bacterial membranes and increase the drug’s availability inside bacterial cells, thereby improving its antimicrobial efficacy and safety profile. Multifunctional antibiotics, formulated as drug delivery systems per se, that take the drug to the site of action, maximize its efficacy, and provide optical detectability are envisaged as the future in fighting against infections. Their role as a tool against multiresistant strains remains as interesting challenge open for further research.
format Online
Article
Text
id pubmed-9653501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96535012022-11-15 Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability Vukomanovic, Marija Gazvoda, Lea Kurtjak, Mario Hrescak, Jitka Jaklic, Blaž Moya-Andérico, Laura Cendra, Maria del Mar Torrents, Eduard Commun Biol Article Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (βCD) cycle and arginine (arg) as a linker, provides more stable ternary antibiotic complex (βCD-arg-cpx). In contrast to classical less stable inclusion complexes, which only modify antibiotic solubility, here-presented ternary complex is more stable and controls drug release. The components of the complex intensify interactions with bacterial membranes and increase the drug’s availability inside bacterial cells, thereby improving its antimicrobial efficacy and safety profile. Multifunctional antibiotics, formulated as drug delivery systems per se, that take the drug to the site of action, maximize its efficacy, and provide optical detectability are envisaged as the future in fighting against infections. Their role as a tool against multiresistant strains remains as interesting challenge open for further research. Nature Publishing Group UK 2022-11-12 /pmc/articles/PMC9653501/ /pubmed/36371541 http://dx.doi.org/10.1038/s42003-022-04197-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Vukomanovic, Marija
Gazvoda, Lea
Kurtjak, Mario
Hrescak, Jitka
Jaklic, Blaž
Moya-Andérico, Laura
Cendra, Maria del Mar
Torrents, Eduard
Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
title Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
title_full Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
title_fullStr Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
title_full_unstemmed Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
title_short Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
title_sort development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653501/
https://www.ncbi.nlm.nih.gov/pubmed/36371541
http://dx.doi.org/10.1038/s42003-022-04197-9
work_keys_str_mv AT vukomanovicmarija developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT gazvodalea developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT kurtjakmario developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT hrescakjitka developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT jaklicblaz developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT moyaandericolaura developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT cendramariadelmar developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability
AT torrentseduard developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability